Sumitomo Pharma Co., Ltd.

OTCPK:DNPU.F Stock Report

Market Cap: US$7.1b

Sumitomo Pharma Management

Management criteria checks 1/4

Sumitomo Pharma's CEO is Toru Kimura, appointed in Jan 2016, has a tenure of 9.58 years. directly owns 0.025% of the company’s shares, worth $1.76M. The average tenure of the management team and the board of directors is 3 years and 1.6 years respectively.

Key information

Toru Kimura

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure10yrs
CEO ownership0.02%
Management average tenure3yrs
Board average tenure1.6yrs

Recent management updates

Recent updates

CEO

Toru Kimura (65 yo)

10yrs
Tenure

Mr. Toru Kimura, Ph D., is Representative Director, President & CEO of Sumitomo Pharma Co. Ltd. from June 25, 2024.Mr. Toru serves as Director at Sumitomo Pharma America, Inc. since 2024. He served as Rep...

Leadership Team

NamePositionTenureCompensationOwnership
Toru Kimura
President10yrsno data0.025%
$ 1.8m
Kimihiro Mizuno
Executive Officer of Legal & Compliance; Intellectual Property & Human Resources1.1yrsno datano data
Koichi Kozuki
E.O. of Corp. Reg. Comp.3yrsno datano data
Isao Shimizu
Exec. Off.3yrsno datano data
Kenji Ueno
Executive Officer3yrsno datano data
Hideyuki Harada
Mng. Exe. Off. of Supply Chain Div.4.8yrsno datano data
Tsutomu Nakagawa
Managing Executive Officer & Director3yrsno data0.00076%
$ 54.1k
Yumi Sato
Managing Exe. Officer of Research & Dev. Div. Senior VP and Head of Research & Development Division3yrsno datano data
Motoyuki Sakai
EVP of Glob. Corp. Strat.less than a yearno data0.0025%
$ 179.5k
Koji Yamazaki
Exec. Off. of Sales & Mark. Div.1.1yrsno datano data
3.0yrs
Average Tenure
64yo
Average Age

Experienced Management: DNPU.F's management team is considered experienced (3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Toru Kimura
President9.6yrsno data0.025%
$ 1.8m
Tsutomu Nakagawa
Managing Executive Officer & Director1.6yrsno data0.00076%
$ 54.1k
Motoyuki Sakai
EVP of Glob. Corp. Strat.1.6yrsno data0.0025%
$ 179.5k
Minoru Usui
Independent Outside Director4.6yrsno datano data
Hiroshi Niinuma
Director1.6yrsno datano data
Daishiro Michimori
Outside Independent Directorless than a yearno datano data
Yoshio Iteya
Outside Independent Directorless than a yearno datano data
Hisayoshi Kashima
Directorless than a yearno data0.0045%
$ 322.7k
Mayumi Mochizuki
Outside Independent Directorless than a yearno datano data
Koji Fujimoto
Independent Outside Director3.6yrsno datano data
1.6yrs
Average Tenure
66yo
Average Age

Experienced Board: DNPU.F's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/16 11:11
End of Day Share Price 2025/12/12 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sumitomo Pharma Co., Ltd. is covered by 17 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Atsushi SekiBarclays
Ritsuo WatanabeBofA Global Research
Hidemaru YamaguchiCitigroup Inc